Heat shock protein 90 alpha (Hsp90α) is an abundantly expressed and evolutionarily
conserved molecular chaperone. Hsp90α is the inducible Hsp90 isoform, and its expression …

In the past few decades, the development of heat shock protein 90 (Hsp90) inhibitors for
cancer treatment has not stopped. About twenty compounds have been evaluated in the …

“Extracellular” Heat Shock Protein-90 (Hsp90) was initially reported in the 1970s but was not
formally recognized until 2008 at the 4th International Conference on The Hsp90 Chaperone …

Heat shock protein 90β (Hsp90β, encoded by Hsp90ab1 gene) is the most abundant
proteins in the cells and contributes to variety of biological processes including metabolism …

Background Plasma heat shock protein 90 alpha (Hsp90α) has been suggested as a novel
biomarker for the diagnosis and prognosis of cancer. Carcinoembryonic antigen (CEA) and …

Colorectal cancer (CRC) is a type of cancer with high morbidity and mortality in several
developing and developed countries of the world. Its mortality and morbidity are predicted to …

Background Colorectal cancer (CRC), the third most commonly diagnosed and second most
lethal cancer worldwide, necessitates efficient early detection strategies to improve patient …

Purpose Extracellular heat shock protein 90 AA1 (eHSP90α) is intricately linked to tumor
progression and prognosis. This study aimed to investigate the difference in the value of …

“Extracellular” Heat Shock Protein-90 (Hsp90) was initially reported in the 1970s but was not
formally recognized until 2008 at the 4th International Conference on The Hsp90 Chaperone …

Horses are used in a variety of disciplines, including dressage, show jumping, eventing and
racing. Thus, the equine athlete is predisposed to the development of musculoskeletal …